Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Award ceilingup to $250,000
Records whose stated use of funds is validation of pharmacodynamic markers and markers of toxicity, exactly as the source published it.
2 of 3 records carry a stated deadline; 0 are rolling and the rest read Not stated.
Counted from linked records only.